Prosecution Insights
Last updated: October 04, 2026

Bose Mckinney & Evans LLP

Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering

49 pending office actions • 11 clients • 47 examiners • 26 art units • 0 of 49 (0%) have an AI response strategy ready

Analysis

BOSE MCKINNEY & EVANS LLP operates in the Medical Devices & Mechanical Engineering technology area. The firm has a career history of 1539 applications. Currently, the firm is managing 34 pending office actions, which constitutes its active prosecution workload.

The firm's resolved allowance rate is 86.62 percent. Achieving an allowance requires an average of 3.66 office actions. This average suggests that the firm frequently engages in multiple rounds of prosecution to secure patent rights for its clients in the medical and mechanical fields. The 86.62 percent allowance rate reflects a high level of success in these efforts. With 34 pending actions, the firm maintains an active presence in the prosecution of mechanical and medical device technologies. Practitioners can use the 3.66 average office actions per allowance and the 1539 career applications to evaluate the firm's long-term performance and reliability in these technical sectors.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=1539 apps, methodology: how we score firms)

86.6%
Allowance Rate
n=1539
+0.70σ
Allowance Rate (norm)
n=1539
3.7
OAs to Allowance
n=900
-0.16σ
OAs to Allow (norm)
n=900
1178 days
Time to Allowance
n=900
+16.4pp
Interview Lift
n=1539
31.0%
RCE Rate
n=1539
1.2%
Appeal Rate
n=1539

Rejection Performance (% of received rejections ultimately overcome)

71.4%
§101 Overcome
n=91
81.0%
§102 Overcome
n=416
81.3%
§103 Overcome
n=705
83.6%
§112 Overcome
n=452

Specialization & Scale

A61B, G01N, Y10T
Top CPC Subclasses
23%
Top-3 CPC Share
n=1539
2
Practitioners
n=1539
769.5
Apps / Practitioner
n=1539

Portfolio Summary

49
Total Pending OAs
35
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

11
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (11)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

25
Hard (51%)
23
Medium (47%)
1
Easy (2%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only4 (8%)
§101 + other1 (2%)
§103 only16 (33%)
§102 only4 (8%)
§112 only1 (2%)
Double-patenting + other3 (6%)
Multi-statute (no §101)20 (41%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
31% of docket
3
Information Tech
6% of docket
0
Communications
0% of docket
3
Semiconductors
6% of docket
16
Mechanical / Eng
33% of docket
12
Business / Other
24% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

490 h
Manual time on pending OAs
98 h
Time saved (low, 20%)
172 h
Time saved (mid, 35%)
4.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TRAN, VIVIAN AILINH 2 55.2% +43.0%
GZYBOWSKI, MICHAEL STANLEY 2 68.3% +52.0%
MAI, THIEN T 1 59.2% +19.8%
LEA EDMONDS, LISA S 1 86.9% +4.9%
MATES, ROBERT E 1 57.0% +35.0%
MCDONNOUGH, COURTNEY G 1 81.6% +18.1%
FARDANESH, MARJAN 1 72.6% +18.9%
TIGHE, BRENDAN P 1 76.0% +19.3%
RODRIGUEZ, JOSEPH C 1 78.4% +15.8%
BERHANU, ETSUB D 1 65.3% +24.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19082273 OPTICAL PROBE AND RELATED METHODS MCDONNOUGH, COURTNEY G —

Hard Cases (25)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17487940 METHOD AND SYSTEM FOR DETERMINING A RELATIVE RISK FOR LACK OF GLYCEMIC CONTROL FOR A PLURALITY OF PATIENTS HOFFPAUIR, ANDREW ELI 89d overdue
17567620 IMPLANTATION NEEDLE FOR INSERTING A SUBCUTANEOUSLY INSERTABLE ELEMENT INTO A BODY TISSUE STIGELL, THEODORE J 46d overdue
18438235 REGULATION OF A TWO-ELECTRODE ANALYTE SENSOR SUN, CAITLYN MINGYUN 24d overdue
18758236 METHOD FOR MANAGING MEDICAL DATA HUYNH, EMILY 23d overdue
17824716 METHOD OF PERFORMING AN ANALYTICAL MEASUREMENT GZYBOWSKI, MICHAEL STANLEY 22d overdue
18361513 SO2-BASED ELECTROLYTE FOR A RECHARGEABLE BATTERY CELL AND RECHARGEABLE BATTERY CELL WHITE, SADIE 16d overdue
18501834 ANALYTE SENSOR AND A METHOD FOR ITS PRODUCING TRAN, VIVIAN AILINH 27d
18415736 OPENING FORMATION IN A MEMBRANE TRAN, VIVIAN AILINH 63d

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17824716 METHOD OF PERFORMING AN ANALYTICAL MEASUREMENT GZYBOWSKI, MICHAEL STANLEY 22d overdue
18501834 ANALYTE SENSOR AND A METHOD FOR ITS PRODUCING TRAN, VIVIAN AILINH 27d
18415736 OPENING FORMATION IN A MEMBRANE TRAN, VIVIAN AILINH 63d
19410489 MEDICAL DEVICE HAVING A TEMPERATURE SENSITIVE ACTIVATION LABEL MAI, THIEN T —
19086874 ROTOR FOR AN EXTERNAL ROTOR MOTOR MATES, ROBERT E —
19082273 OPTICAL PROBE AND RELATED METHODS MCDONNOUGH, COURTNEY G —
19036983 METHOD AND AN ANALYTE SENSOR SYSTEM FOR DETECTING AT LEAST ONE ANALYTE FARDANESH, MARJAN —
19004137 DISTRIBUTION SYSTEM AND METHOD FOR DISTRIBUTING A PLURALITY OF CARRIERS TIGHE, BRENDAN P —

Client Portfolio (11 clients)

Top Art Units

Art UnitApps
37917
37834
17942
17982
28761
28581
36621
21611
28341
36831

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19410489 MEDICAL DEVICE HAVING A TEMPERATURE SENSITIVE ACTIVATION LABEL Roche Diabetes Care, Inc. MAI, THIEN T 2876 §102§103 Non-Final OA — Pending Dec 05, 2025
19086716 HOUSING FOR AN ELECTRICAL OR ELECTRONIC DEVICE BORGWARNER, INC. LEA EDMONDS, LISA S §102§112 Non-Final OA — Pending Mar 21, 2025
19086874 ROTOR FOR AN EXTERNAL ROTOR MOTOR BORGWARNER, INC. MATES, ROBERT E §103 Non-Final OA — Pending Mar 21, 2025
19082273 OPTICAL PROBE AND RELATED METHODS Keystone Photonics GmbH MCDONNOUGH, COURTNEY G 2858 §103 Non-Final OA — Pending Mar 18, 2025
19036983 METHOD AND AN ANALYTE SENSOR SYSTEM FOR DETECTING AT LEAST ONE ANALYTE Roche Diabetes Care, Inc. FARDANESH, MARJAN §102 Non-Final OA — Pending Jan 24, 2025
19004137 DISTRIBUTION SYSTEM AND METHOD FOR DISTRIBUTING A PLURALITY OF CARRIERS Roche Diagnostics Operations, Inc. TIGHE, BRENDAN P §102 Non-Final OA — Pending Dec 27, 2024
19004068 SAFE POINT PATTERN Roche Diagnostics Operations, Inc. RODRIGUEZ, JOSEPH C 3662 §102§103§112 Non-Final OA — Pending Dec 27, 2024
18947053 ANALYTE SENSOR MORPHOLOGY Roche Diabetes Care, Inc. BERHANU, ETSUB D §102§103§112 Non-Final OA — Pending Nov 14, 2024
18919086 METHOD AND SYSTEM FOR STORING MEASUREMENT DATA DETECTED BY A SENSOR DEVICE AND INDICATIVE OF AN ANALYTE IN A SAMPLE OF A BODILY FLUID Roche Diabetes Care, Inc. BIBBEE, JARED M 2161 §102§103Other Final Rejection — Pending Oct 17, 2024
18899202 INSERTION SYSTEM Roche Diabetes Care, Inc. XU, JUSTIN §102 Non-Final OA — Pending Sep 27, 2024
18884634 INFUSION DELIVERY DEVICE Roche Diabetes Care, Inc. VOKES, KATHLEEN PAIGE §102§103 Non-Final OA — Pending Sep 13, 2024
18799705 METHODS AND DEVICES FOR DETERMINING THE CONCENTRATION OF AT LEAST ONE ANALYTE IN A BODY FLUID Roche Diabetes Care, Inc. KEUP, AIDAN JAMES §103 Non-Final OA — Pending Aug 09, 2024
18798243 BODY-WEARABLE MEDICAL DEVICE COMPRISING A SUPERABSORBENT SUBSTANCE Roche Diabetes Care, Inc. WHITROCK, ZACHARIAH KIRBY §103§112 Non-Final OA — Pending Aug 08, 2024
18774381 MEDICAL SYSTEM AND METHOD OF MANUFACTURING THEREOF Roche Diabetes Care, Inc. CATINA, MICHAEL ANTHONY 3791 §103§112Other Non-Final OA — Pending Jul 16, 2024
18769358 ELECTRIC MOTOR BORGWARNER, INC. SUBRAMANIAN, VISWANATHAN 2834 §102§103 Final Rejection — Pending Jul 10, 2024
18758236 METHOD FOR MANAGING MEDICAL DATA Roche Diabetes Care, Inc. HUYNH, EMILY 3683 §101 Non-Final OA 23d overdue Pending Jun 28, 2024
18749768 ANKLE FOOT ORTHOSIS AND METHOD OF MAKING AND USING Step Ahead Medical LLC RODRIQUEZ, KARI KRISTIN 3786 §103 Final Rejection — Pending Jun 21, 2024
18749276 BODY WEARABLE ANALYTE SENSOR SYSTEM WITH INFRARED TEMPERATURE SENSOR DEVICE Roche Diabetes Care, Inc. TOTH, KAREN E 3791 §102§103§112 Non-Final OA — Pending Jun 20, 2024
18639062 SYSTEM AND METHOD FOR AUTOMATED OPTICAL ANALYTE MEASUREMENTS VIA WEARABLE SMART DEVICES Roche Diabetes Care, Inc. KRCHA, MATTHEW D §103§112 Non-Final OA — Pending Apr 18, 2024
18621012 BIODEGRADABLE MOLDABLE SOY-BASED FOAMS Indiana Soybean Alliance, Inc. WILLIAMS, EMMALEE RAE 1653 §103§112 Non-Final OA — Pending Mar 28, 2024
18611917 SENSOR WITH VARYING STIFFNESS Roche Diabetes Care, Inc. CERIONI, DANIEL LEE 3791 §102§112 Non-Final OA — Pending Mar 21, 2024
18583979 METHODS AND DEVICES FOR CONTROLLING AUTO WHITE BALANCE SETTINGS OF A MOBILE DEVICE FOR A COLOR BASED MEASUREMENT USING A COLOR REFERENCE CARD Roche Diabetes Care, Inc. ABDI, AMARA §101 Non-Final OA — Pending Feb 22, 2024
18438235 REGULATION OF A TWO-ELECTRODE ANALYTE SENSOR Roche Diabetes Care, Inc. SUN, CAITLYN MINGYUN 1795 §102§103 Non-Final OA 24d overdue Pending Feb 09, 2024
18415736 OPENING FORMATION IN A MEMBRANE Roche Diabetes Care, Inc. TRAN, VIVIAN AILINH 1794 §103§112Other Final Rejection 63d Pending Jan 18, 2024
18543539 ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE In The Bowl Animal Health, Inc. MITCHELL, EDWIN COLEMAN 1619 §103DP Final Rejection 5d overdue Pending Dec 18, 2023
18543411 ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE In The Bowl Animal Health, Inc. LAU, JONATHAN S 1793 §103§112DP Non-Final OA — Pending Dec 18, 2023
18512977 HEATER AND METHOD FOR PRODUCING A HEATER Borgwarner Lnc. ELLIOTT, TOPAZ L §102§103 Non-Final OA — Pending Nov 17, 2023
18501834 ANALYTE SENSOR AND A METHOD FOR ITS PRODUCING Roche Diabetes Care, Inc. TRAN, VIVIAN AILINH 1794 §103§112 Non-Final OA 27d Pending Nov 03, 2023
18491782 MEDICAL DEVICE SYSTEM, AND DISPOSABLE CONTAINER Roche Diabetes Care, Inc. SHAH, NILAY J 3783 §102 Final Rejection 13d Pending Oct 22, 2023
18483369 COOLING MODULE FOR BATTERIES OF AN ELECTRIC OR HYBRID VEHICLE Borgwarner Lnc. TAKEUCHI, YOSHITOSHI 1723 §103DP Non-Final OA — Pending Oct 09, 2023
18452096 MEANS AND METHODS FOR IMPLANTING CELLS SECRETING A THERAPEUTIC COMPOUND Roche Diabetes Care, Inc. GRAY, PHILLIP A 3783 §103 Non-Final OA 43d Pending Aug 18, 2023
18361513 SO2-BASED ELECTROLYTE FOR A RECHARGEABLE BATTERY CELL AND RECHARGEABLE BATTERY CELL Innolith Technology AG WHITE, SADIE 1721 §102§103 Non-Final OA 16d overdue Pending Jul 28, 2023
18361595 RECHARGEABLE BATTERY CELL Innolith Technology AG FRANCIS, ADAM JOSEPH 1728 §103Other Non-Final OA 50d Pending Jul 28, 2023
18322335 METHOD FOR PREPARING A COUNTER/REFERENCE ELECTRODE Roche Diabetes Care, Inc. NGUYEN, DONGHAI D 3729 §103 Final Rejection 22d Pending May 23, 2023
18315858 METHOD FOR PRODUCING AN ANALYTE SENSOR, AN ANALYTE SENSOR, AND A USE THEREOF Roche Diabetes Care, Inc. KRETZER, KYLE W. 3791 §103 Non-Final OA 28d Pending May 11, 2023
18300106 METHOD OF CONTROLLING AUTO-EXPOSURE SETTINGS OF A MOBILE DEVICE HAVING A CAMERA Roche Diabetes Care, Inc. DANG, HUNG Q 2484 §103 Non-Final OA — Pending Apr 13, 2023
18163101 METHOD FOR DISPLAYING A MEDICAL VALUE Roche Diabetes Care, Inc. PARCHER, DANIEL W 2174 §102§103 Non-Final OA — Pending Feb 01, 2023
17822352 MEDICAL SYSTEM AND METHOD OF STERILITY TESTING THE MEDICAL SYSTEM Roche Diabetes Care, Inc. MCCORMACK, ERIN KATHLEEN 3791 §103 Final Rejection — Pending Aug 25, 2022
17824542 METHODS AND DEVICES FOR PERFORMING AN ANALYTICAL MEASUREMENT Roche Diabetes Care, Inc. GZYBOWSKI, MICHAEL STANLEY 1798 §101§103 Final Rejection — Pending May 25, 2022
17824716 METHOD OF PERFORMING AN ANALYTICAL MEASUREMENT Roche Diabetes Care, Inc. GZYBOWSKI, MICHAEL STANLEY 1798 §101 Final Rejection 22d overdue Pending May 25, 2022
17743009 ADJUSTMENT METHOD FOR AN ANALYTICAL DETERMINATION OF AN ANALYTE IN A BODY FLUID Roche Diabetes Care, Inc. ELKINS, BLAKE HARRISON 1687 §103 Final Rejection 8d overdue Pending May 12, 2022
17665042 MEDICAL DEVICE WITH TACTILE INDICATION Roche Diabetes Care, Inc. MARRISON, SAMUEL JOSEPH 3783 §103 Final Rejection 5d overdue Pending Feb 04, 2022
17567620 IMPLANTATION NEEDLE FOR INSERTING A SUBCUTANEOUSLY INSERTABLE ELEMENT INTO A BODY TISSUE Roche Diabetes Care, Inc. STIGELL, THEODORE J 3783 §102§103 Non-Final OA 46d overdue Pending Jan 03, 2022
17487940 METHOD AND SYSTEM FOR DETERMINING A RELATIVE RISK FOR LACK OF GLYCEMIC CONTROL FOR A PLURALITY OF PATIENTS Mysugr GmbH HOFFPAUIR, ANDREW ELI 3791 §101 Non-Final OA 89d overdue Pending Sep 28, 2021
17313660 METHOD AND SYSTEM OF DETERMINING A PROBABILITY OF A BLOOD GLUCOSE VALUE FOR A PATIENT BEING IN AN ADVERSE BLOOD GLUCOSE RANGE AT A PREDICTION TIME Mysugr GmbH SKIBINSKY, ANNA 1635 §103 Non-Final OA 68d Pending May 06, 2021
17284586 IMMUNOASSAY FOR MEASURING C-PEPTIDE Roche Diabetes Care Inc. KIRWIN, STEFANIE JOHANNA 1677 §103 Non-Final OA — Pending Apr 12, 2021
17262016 DEVICES AND METHOD FOR MEASURING AN ANALYTE CONCENTRATION IN A SAMPLE OF BODILY FLUID Roche Diabetes Care, Inc. HUANG, MICKEY NMN 1758 §103 Final Rejection 98d overdue Pending Jan 21, 2021
16724893 METHOD AND SYSTEM FOR DETECTING AN OPERATION STATUS FOR A SENSOR Roche Diabetes Care, Inc. PORTER, RACHEL L 3684 §112 Non-Final OA 17d overdue Pending Dec 23, 2019
15486948 SYSTEM FOR IN-VIVO MEASUREMENT OF AN ANALYTE CONCENTRATION Roche Diabetes Care, Inc. AGAHI, PUYA 3791 §103 Final Rejection — Pending Apr 13, 2017

Managing Bose Mckinney & Evans LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month